It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2019.
2019 | Hyderabad, Telangana, India | ActiveAelmar Pharmaceutical Private Limited, a active private limited company, was established on 29 March 2019 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74990TG2019PTC131714. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Aditya Kalyanrao Patil (Director), Abdul Rahil Quadeer Abdul (Director). Past directors included Salman Siddiqui Khan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1-9-698/1-4, Flat No-405, B Block, 4Th Floor, Naik Prudvi Golden Towers, Hyderabad, Telangana, 500044.
U74990TG2019PTC131714
131714
29 March 2019
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aelmar Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Kalyanrao Patil | Director | 29 Mar 2019 | Current |
| Abdul Rahil Quadeer Abdul | Director | 29 Mar 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aelmar Pharmaceutical Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.02% decrease. The company also saw a substantial fall in profitability, with a 48.21% decrease in profit. The company's net worth Soared by an impressive increase of 16.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Aelmar Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aelmar Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aelmar Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aelmar Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aelmar Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Aelmar Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Aditya Kalyanrao Patil was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 8 months . was recorded as a recent event.
Progress on Abdul Rahil Quadeer Abdul was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 8 months . was documented.
Progress on Aelmar Pharmaceutical Private Limited was registered on 29 Mar 2019 with Roc Hyderabad & aged 6 years 8 months as per MCA records. was documented.
The CIN of Aelmar Pharmaceutical Private Limited is U74990TG2019PTC131714.
Aelmar Pharmaceutical Private Limited is headquartered at 1-9-698/1-4, Flat No-405, B Block, 4Th Floor, Naik Prudvi Golden Towers, Hyderabad, Telangana, 500044.
Aelmar Pharmaceutical Private Limited was incorporated on 29 March 2019.
The current directors of Aelmar Pharmaceutical Private Limited are
The primary industry of Aelmar Pharmaceutical Private Limited is Pharma.
Aelmar Pharmaceutical Private Limited is unlisted.
The authorized capital of Aelmar Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX